FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121690400> ?p ?o ?g. }

• W2121690400 endingPage "905" @default.
• W2121690400 startingPage "898" @default.
• W2121690400 abstract "The multiple-dose pharmacokinetics of ritonavir were investigated in four groups of human immunodeficiency virus-positive male subjects (with 16 subjects per group) under nonfasting conditions; a 3:1 ritonavir:placebo ratio was used. Ritonavir was given at 200 (group I), 300 (group II), 400 (group III), or 500 (group IV) mg every 12 h for 2 weeks. The multiple-dose pharmacokinetics of ritonavir were moderately dose dependent, with the clearance for group IV (6.8 +/- 2.7 liters/h) being an average of 32% lower than that for group I (10.0 +/- 3.2 liters/h). First-pass metabolism should be minimal for ritonavir. The functional half-life, estimated from peak and trough concentrations, were similar among the dosage groups, averaging 3.1 and 5.7 h after the morning and evening doses, respectively. The area under the concentration-time curve at 24 h (AUC24) and apparent terminal-phase elimination rate constant remained relatively time invariant, but predose concentrations decreased 30 to 70% over time. Concentration-dependent autoinduction is the most likely mechanism for the time-dependent pharmacokinetics. The Km and initial maximum rate of metabolism (Vmax) values estimated from population pharmacokinetic modeling (nonlinear mixed-effects models) were 3.43 microg/ml and 46.9 mg/h, respectively. The group IV Vmax increased to 68 mg/h after 2 weeks. The maximum concentration of ritonavir in serum (Cmax) and AUC after the evening doses were an average of 30 to 40% lower than the values after the morning doses, while the concentration at 12 h was an average of 32% lower than the predose concentration, probably due to protracted absorption. Less than 2% of the dose was eliminated unchanged in the urine. Triglyceride levels increased from the levels at the baseline, and the levels were correlated with baseline triglyceride levels and AUC, Cmax, or predose concentrations." @default.
• W2121690400 created "2016-06-24" @default.
• W2121690400 creator A5000035949 @default.
• W2121690400 creator A5002050606 @default.
• W2121690400 creator A5003737190 @default.
• W2121690400 creator A5012444317 @default.
• W2121690400 creator A5018794013 @default.
• W2121690400 creator A5026490040 @default.
• W2121690400 creator A5028902741 @default.
• W2121690400 creator A5034382194 @default.
• W2121690400 creator A5035346884 @default.
• W2121690400 creator A5038792431 @default.
• W2121690400 creator A5046460708 @default.
• W2121690400 creator A5063337297 @default.
• W2121690400 creator A5063863815 @default.
• W2121690400 creator A5066149189 @default.
• W2121690400 creator A5082700686 @default.
• W2121690400 date "1997-05-01" @default.
• W2121690400 modified "2023-10-18" @default.
• W2121690400 title "Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects" @default.
• W2121690400 cites W1974224443 @default.
• W2121690400 cites W1987688509 @default.
• W2121690400 cites W1990338345 @default.
• W2121690400 cites W2007366202 @default.
• W2121690400 cites W2011630381 @default.
• W2121690400 cites W2022098233 @default.
• W2121690400 cites W2023198078 @default.
• W2121690400 cites W2038657917 @default.
• W2121690400 cites W2045241078 @default.
• W2121690400 cites W2050102180 @default.
• W2121690400 cites W2057865208 @default.
• W2121690400 cites W2061591861 @default.
• W2121690400 cites W2094019929 @default.
• W2121690400 cites W2097916721 @default.
• W2121690400 cites W2115837402 @default.
• W2121690400 cites W2130082288 @default.
• W2121690400 cites W2132185205 @default.
• W2121690400 cites W2133443209 @default.
• W2121690400 cites W2266901547 @default.
• W2121690400 cites W2339057709 @default.
• W2121690400 cites W39537358 @default.
• W2121690400 doi "https://doi.org/10.1128/aac.41.5.898" @default.
• W2121690400 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/163822" @default.
• W2121690400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9145841" @default.
• W2121690400 hasPublicationYear "1997" @default.
• W2121690400 type Work @default.
• W2121690400 sameAs 2121690400 @default.
• W2121690400 citedByCount "171" @default.
• W2121690400 countsByYear W21216904002012 @default.
• W2121690400 countsByYear W21216904002013 @default.
• W2121690400 countsByYear W21216904002014 @default.
• W2121690400 countsByYear W21216904002015 @default.
• W2121690400 countsByYear W21216904002016 @default.
• W2121690400 countsByYear W21216904002017 @default.
• W2121690400 countsByYear W21216904002018 @default.
• W2121690400 countsByYear W21216904002019 @default.
• W2121690400 countsByYear W21216904002020 @default.
• W2121690400 countsByYear W21216904002021 @default.
• W2121690400 countsByYear W21216904002022 @default.
• W2121690400 countsByYear W21216904002023 @default.
• W2121690400 crossrefType "journal-article" @default.
• W2121690400 hasAuthorship W2121690400A5000035949 @default.
• W2121690400 hasAuthorship W2121690400A5002050606 @default.
• W2121690400 hasAuthorship W2121690400A5003737190 @default.
• W2121690400 hasAuthorship W2121690400A5012444317 @default.
• W2121690400 hasAuthorship W2121690400A5018794013 @default.
• W2121690400 hasAuthorship W2121690400A5026490040 @default.
• W2121690400 hasAuthorship W2121690400A5028902741 @default.
• W2121690400 hasAuthorship W2121690400A5034382194 @default.
• W2121690400 hasAuthorship W2121690400A5035346884 @default.
• W2121690400 hasAuthorship W2121690400A5038792431 @default.
• W2121690400 hasAuthorship W2121690400A5046460708 @default.
• W2121690400 hasAuthorship W2121690400A5063337297 @default.
• W2121690400 hasAuthorship W2121690400A5063863815 @default.
• W2121690400 hasAuthorship W2121690400A5066149189 @default.
• W2121690400 hasAuthorship W2121690400A5082700686 @default.
• W2121690400 hasBestOaLocation W21216904001 @default.
• W2121690400 hasConcept C112705442 @default.
• W2121690400 hasConcept C121332964 @default.
• W2121690400 hasConcept C126322002 @default.
• W2121690400 hasConcept C1276947 @default.
• W2121690400 hasConcept C139254425 @default.
• W2121690400 hasConcept C142462285 @default.
• W2121690400 hasConcept C185592680 @default.
• W2121690400 hasConcept C192670549 @default.
• W2121690400 hasConcept C19720800 @default.
• W2121690400 hasConcept C203014093 @default.
• W2121690400 hasConcept C22979827 @default.
• W2121690400 hasConcept C2776476923 @default.
• W2121690400 hasConcept C2779298103 @default.
• W2121690400 hasConcept C2908647359 @default.
• W2121690400 hasConcept C2910800852 @default.
• W2121690400 hasConcept C2993143319 @default.
• W2121690400 hasConcept C3013748606 @default.
• W2121690400 hasConcept C71924100 @default.
• W2121690400 hasConcept C98274493 @default.
• W2121690400 hasConcept C99454951 @default.
• W2121690400 hasConceptScore W2121690400C112705442 @default.

• next